Brief: Promore Pharma Q3 Net Loss Narrows To SEK 6.1 Mln

PMD Device Solutions AB

23/11/2021 12:18

Nov 23 (Reuters) - Promore Pharma AB  PROMO.ST :
    * INTERIM REPORT JANUARY - SEPTEMBER 2021
    * Q3 NET SALES AMOUNTED TO MSEK 0 (0)
    * Q3 NET LOSS WAS MSEK -6.1 (-8.1), CORRESPONDING TO
EARNINGS PER
SHARE OF SEK -0.11 (-0.22)

Source text for Eikon:  ID:nMFN39CMDc 
Further company coverage:  PROMO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))